Found: 39
Select item for more details and to access through your institution.
Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 8, p. 2020
- By:
- Publication type:
- Article
96 week results from the MONET trial: a randomized comparison of darunavir/ritonavir with versus without nucleoside analogues, for patients with HIV RNA <50 copies/mL at baseline.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 8, p. 1878, doi. 10.1093/jac/dkr199
- By:
- Publication type:
- Article
Safety of etravirine in HIV-1/hepatitis B and/or C virus co-infected patients: pooled 96 week results from the Phase III DUET trials.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 11, p. 2450, doi. 10.1093/jac/dkq332
- By:
- Publication type:
- Article
Sequential treatment with 5-aza-2′-deoxycytidine and deacetylase inhibitors reactivates HIV-1.
- Published in:
- EMBO Molecular Medicine, 2016, v. 8, n. 2, p. 117, doi. 10.15252/emmm.201505557
- By:
- Publication type:
- Article
The challenge: streamlining HIV treatment and care while improving outcomes.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19493
- By:
- Publication type:
- Article
High-risk human papillomavirus infection in HIV-positive African women living in Europe.
- Published in:
- Journal of the International AIDS Society, 2013, v. 16, n. 1, p. 1, doi. 10.7448/IAS.16.1.18023
- By:
- Publication type:
- Article
Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study.
- Published in:
- Journal of the International AIDS Society, 2011, v. 14, n. 1, p. 1, doi. 10.1186/1758-2652-14-16
- By:
- Publication type:
- Article
Treatment of Toxoplasmic Encephalitis in Patients with AIDS.
- Published in:
- Annals of Internal Medicine, 1992, v. 116, n. 1, p. 33, doi. 10.7326/0003-4819-116-1-33
- By:
- Publication type:
- Article
Randomized Trial to Evaluate Indinavir/Ritonavir versus Saquinavir/Ritonavir in Human Immunodeficiency Virus Type 1--Infected Patients: The MaxCmin1 Trial.
- Published in:
- Journal of Infectious Diseases, 2003, v. 188, n. 5, p. 635
- By:
- Publication type:
- Article
Virological and Immunological Effects of Combination Antiretroviral Therapy with Zidovudine...
- Published in:
- Journal of Infectious Diseases, 2000, v. 182, n. 3, p. 950, doi. 10.1086/315753
- By:
- Publication type:
- Article
HIV-Associated Multinucleated Giant Cells in Lymphoid Tissue of the Waldeyer’s Ring: A Detailed Study.
- Published in:
- Modern Pathology, 2000, v. 13, n. 12, p. 1293, doi. 10.1038/modpathol.3880237
- By:
- Publication type:
- Article
Limited HIV-1 Reactivation in Resting CD4<sup>+</sup> T cells from Aviremic Patients under Protease Inhibitors.
- Published in:
- Scientific Reports, 2016, p. 38313, doi. 10.1038/srep38313
- By:
- Publication type:
- Article
Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line.
- Published in:
- Scientific Reports, 2016, p. 24090, doi. 10.1038/srep24090
- By:
- Publication type:
- Article
Feasibility and Effectiveness of Indicator Condition-Guided Testing for HIV: Results from HIDES I (HIV Indicator Diseases across Europe Study).
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0052845
- By:
- Publication type:
- Article
Resistance at Virological Failure Using Boosted Protease Inhibitors Versus Nonnucleoside Reverse Transcriptase Inhibitors As First-Line Antiretroviral Therapy—Implications for Sustained Efficacy of ART in Resource-Limited Settings.
- Published in:
- Journal of Infectious Diseases, 2013, v. 207, n. suppl_2, p. S78, doi. 10.1093/infdis/jit112
- By:
- Publication type:
- Article
Resistance at Virological Failure Using Boosted Protease Inhibitors Versus Nonnucleoside Reverse Transcriptase Inhibitors As First-Line Antiretroviral Therapy--Implications for Sustained Efficacy of ART in Resource-Limited Settings.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Sustained Viral Suppression and Higher CD4+ T-Cell Count Reduces the Risk of Persistent Cervical High-Risk Human Papillomavirus Infection in HIV-Positive Women.
- Published in:
- Journal of Infectious Diseases, 2013, v. 207, n. 11, p. 1723, doi. 10.1093/infdis/jit090
- By:
- Publication type:
- Article
Maraviroc versus Efavirenz, Both in Combination with Zidovudine-Lamivudine, for the Treatment of Antiretroviral-Naive Subjects with CCR5-Tropic HIV-1 Infection.
- Published in:
- Journal of Infectious Diseases, 2010, v. 201, n. 6, p. 803, doi. 10.1086/650697
- By:
- Publication type:
- Article
A Double-Blind, Placebo-Controlled Trial of Maraviroc in Treatment-Experienced Patients Infected with Non-R5 HIV-1.
- Published in:
- Journal of Infectious Diseases, 2009, v. 199, n. 11, p. 1638, doi. 10.1086/598965
- By:
- Publication type:
- Article
Factors Associated with the Development of Opportunistic Infections in HIV-1-Infected Adults with High CD4 <sup>+</sup> Cell Counts: A EuroSIDA Study.
- Published in:
- Journal of Infectious Diseases, 2006, v. 194, n. 5, p. 633
- By:
- Publication type:
- Article
ACQUIRED IMMUNE DEFICIENCY SYNDROME IN BELGIUM AND ITS RELATION TO CENTRAL AFRICA<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1984, v. 437, n. 1, p. 264, doi. 10.1111/j.1749-6632.1984.tb37144.x
- By:
- Publication type:
- Article
The changing pattern of Kaposi sarcoma in patients with HIV, 1994–2003Performed on behalf of the EuroSIDA Study Group.The following were members of the EuroSIDA multicenter study group (asterisks denote national coordinators): Argentina: M. Losso* and A. Duran (Hospital Jose Maria Ramos Mejia, Buenos Aires); Austria: N. Vetter* (Pulmologisches Zentrum der Stadt Wien, Vienna); Belgium: N. Clumeck*, S. De Wit, K. Kabeya, and B. Poll (Saint‐Pierre Hospital, Brussels); and R. Colebunders (Institute of Tropical Medicine, Antwerp); Czech Republic: L. Machala* and H. Rozsypal (Faculty Hospital Bulovka, Prague); Denmark: J. Nielsen*, J. Lundgren, O. Kirk, and C.H. Olsen (Hvidovre Hospital, Copenhagen); J. Gerstoft, T. Katzenstein, A.‐B.E. Hansen, and P. Skinhøj (Rigshospitalet, Copenhagen); and C. Pedersen (Odense University Hospital, Odense); Estonia: K. Zilmer* and M. Rauka (Tallinn Merimetsa Hospital, Tallinn); France: C. Katlama* and M. De Sa (Hôpital de la Pitié‐Salpétière, Paris); J.‐P.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 12, p. 2644
- By:
- Publication type:
- Article
Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, n. 2, p. 268, doi. 10.1093/cid/ciw236
- By:
- Publication type:
- Article
An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression.
- Published in:
- PLoS Pathogens, 2015, v. 11, n. 7, p. 1, doi. 10.1371/journal.ppat.1005063
- By:
- Publication type:
- Article
Pharmacokinetics of Two Randomized Trials Evaluating the Safety and Efficacy of Indinavir, Saquinavir and Lopinavir in Combination with Low-Dose Ritonavir: The MaxCmin1 and 2 Trials.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2007, v. 101, n. 5, p. 339, doi. 10.1111/j.1742-7843.2007.00117.x
- By:
- Publication type:
- Article
EDITORIAL.
- Published in:
- 1999
- By:
- Publication type:
- Editorial
Biochemical Thyroid Profile in Patients Infected with the Human Immunodeficiency Virus.
- Published in:
- Thyroid, 1991, v. 1, n. 2, p. 147, doi. 10.1089/thy.1991.1.147
- By:
- Publication type:
- Article
Challenging Times for Noncommercial Researchers.
- Published in:
- Applied Clinical Trials, 2006, v. 15, n. 5, p. 58
- By:
- Publication type:
- Article
Standardizing EU Investigative Sites.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 7, p. 38
- By:
- Publication type:
- Article
The EU Directive: Practical Implications for Clinical Research Teams.
- Published in:
- Applied Clinical Trials, 2004, v. 13, n. 5, p. 42
- By:
- Publication type:
- Article
Innovations at an Investigative Site.
- Published in:
- Applied Clinical Trials, 2003, v. 12, n. 6, p. 38
- By:
- Publication type:
- Article
Effects of Switching To Protease Inhibitor Monotherapy on Nucleoside Analogue-Related Adverse Events.
- Published in:
- AIDS Reviews, 2014, v. 16, n. 4, p. 236
- By:
- Publication type:
- Article
Relationship Between Current Level of Immunodeficiency and Non-Acquired Immunodeficiency Syndrome-Defining Malignancies.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 22, p. 5306, doi. 10.1002/cncr.25311
- By:
- Publication type:
- Article
Pyrimethamine-Clindamycin vs. Pyrimethamine-Sulfadiazine as Acute and Long-Term Therapy for Toxoplasmic Encephalitis in Patients with AIDS.
- Published in:
- Clinical Infectious Diseases, 1996, v. 22, n. 2, p. 268
- By:
- Publication type:
- Article
Safety, Tolerability, and Preliminary Efficacy of 48 Weeks of Etravirine Therapy in a Phase IIb Dose-Ranging Study Involving Treatment-Experienced Patients with HIV-1 Infection.
- Published in:
- Clinical Infectious Diseases, 2008, v. 47, n. 7, p. 969, doi. 10.1086/591705
- By:
- Publication type:
- Article
Predictors of Virological Outcome and Safety in Primary HIV Type 1—Infected Patients Initiating Quadruple Antiretroviral Therapy: QUEST GW PROB3005.
- Published in:
- Clinical Infectious Diseases, 2007, v. 45, n. 3, p. 381, doi. 10.1086/519428
- By:
- Publication type:
- Article
Ritonavir-Boosted Tipranavir Demonstrates Superior Efficacy to Ritonavir-Boosted Protease Inhibitors in Treatment-Experienced HIV-Infected Patients: 24-Week Results of the RESIST-2 Trial.
- Published in:
- Clinical Infectious Diseases, 2006, v. 43, n. 10, p. 1347, doi. 10.1086/508352
- By:
- Publication type:
- Article
Possible role of granulocyte-macrophage colony stimulating factor (GM-CSF) on the rapid progression of AIDS-related Kaposi's sarcoma lesions in vivo.
- Published in:
- British Journal of Haematology, 1994, v. 87, n. 2, p. 413, doi. 10.1111/j.1365-2141.1994.tb04934.x
- By:
- Publication type:
- Article